Comments

Monte Rosa Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GLUENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Thu Mar 20th, before the market open

The most recent conference call was at 8:00 AM, 4 days ago Click to view past webcast

Monte Rosa Therapeutics (GLUE) Forecast

News Earnings Monte Rosa Therapeutics (GLUE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Monte Rosa Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:GLUE | Benzinga

Explore Monte Rosa Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GLUE.

Open	$5.85
Close	-
Volume / Avg.	38.73K / 776.84K
Day Range	$5.74 - $5.91
52 Wk Range	3.21 - 12.40
Market Cap	$352.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	23.91%
Days to Cover	19.07

Recent News

Novartis Partner Monte Rosa Therapeutics Touts Positive Data From Early-Stage Study Of Investigational Drug Candidate For Immune-Mediated Disorders

Monte Rosa's MRT-6160 shows promising Phase 1 results, with Novartis backing its development in a deal that could reach $2.1B in milestone payments.

Vandana Singh

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Monte Rosa Therapeutics stock rises as it announces a global licensing deal with Novartis to advance MRT-6160 for immune conditions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.85
Close	-
Volume / Avg.	38.73K / 776.84K
Day Range	$5.74 - $5.91
52 Wk Range	3.21 - 12.40
Market Cap	$352.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	23.91%
Days to Cover	19.07

About Monte Rosa Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Monte Rosa Therapeutics (GLUE) stock?

You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.

View our list of the best stock brokerages

Who are Monte Rosa Therapeutics (GLUE) competitors?

Other companies in Monte Rosa Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Celcuity (NASDAQ:CELC), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and Emergent BioSolutions (NYSE:EBS).

What is the forecast, or price target, for Monte Rosa Therapeutics (GLUE) stock?

Monte Rosa Therapeutics has a consensus price target of $15.75.

What is the current price for Monte Rosa Therapeutics (GLUE)?

The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $5.73 last updated March 24, 2025 at 9:41 AM EDT.

Does Monte Rosa Therapeutics (GLUE) pay a dividend?

There are no upcoming dividends for Monte Rosa Therapeutics.

When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?

Monte Rosa Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Monte Rosa Therapeutics (GLUE) going to split?

There is no upcoming split for Monte Rosa Therapeutics.

What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.